Last updated on June 2020

Phase II Umbrella Study of Novel Anti-cancer Agents in Patients With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy


Find a site near you

Start Over

Research Site

Kfar Saba, Israel
  Connect »

Research Site

Petach-Tikva, Israel
6.61miles
  Connect »

Research Site

Petah Tikva, Israel
6.61miles
  Connect »

Research Site

Ramat Gan, Israel
9.24miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.